Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
704 studies found for:    "melphalan"
Show Display Options
Rank Status Study
1 Recruiting Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment
Condition: Metastatic Melanoma
Intervention: Drug: Melphalan
2 Recruiting A Pharmacokinetic Study of Melphalan in Children
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: Melphalan
3 Terminated Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage
Condition: Retinoblastoma
Intervention: Drug: Melphalan
4 Recruiting Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Intervention: Drug: Melphalan HCl for injection (propylene glycol free)
5 Completed Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Melphalan
6 Completed Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma;   Patient Participation
Intervention: Drug: Doxil, melphalan, bortezomib
7 Recruiting Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
Conditions: Hepatocellular Carcinoma;   Intrahepatic Cholangiocarcinoma
Interventions: Device: Delcath Hepatic Delivery System;   Drug: Melphalan
8 Completed Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Intervention: Drug: High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
9 Recruiting Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib-Melphalan;   Drug: Melphalan
10 Completed
Has Results
A Pharmacokinetic Study of Melphalan HCL for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Interventions: Drug: Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for Injection;   Drug: Alkeran for Injection/Melphalan HCL for Injection (Propylene Glycol-Free)
11 Completed
Has Results
Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Panobinostat
12 Recruiting Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Carfilzomib
13 Terminated Intravitreal Injections of Melphalan for Retinoblastoma
Condition: Retinoblastoma
Intervention: Drug: IVit Melphalan
14 Recruiting Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Bortezomib
15 Unknown  Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®
16 Active, not recruiting
Has Results
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
Condition: Multiple Myeloma
Interventions: Drug: melphalan;   Drug: topotecan (TPT);   Procedure: Autologous Stem Cell Rescue
17 Completed
Has Results
Lenalidomide and High-Dose Melphalan
Conditions: Myeloma;   Stem Cell Transplantation
Interventions: Drug: Lenalidomide;   Drug: Melphalan;   Procedure: Stem Cell Infusion
18 Recruiting Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
Conditions: Multiple Myeloma;   Amyloidosis
Interventions: Device: Melphalan;   Drug: Pegfilgrastim;   Procedure: Autologous Hematopoietic Progenitor Cell Transplant
19 Completed
Has Results
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
Conditions: Multiple Myeloma;   Lymphoma
Interventions: Drug: Busulfan;   Drug: Melphalan
20 Recruiting Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity
Condition: Melanoma
Intervention: Drug: Ipilimumab, Melphalan and Dactinomycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.